Stock Price Forecast

Sept. 29, 2023


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Absci Corp chart...

About the Company

We do not have any company description for Absci Corp at the moment.

Exchange

NASDAQ

$8M

Total Revenue

193

Employees

$122M

Market Capitalization

-1.10

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $ABSI News

Absci lays off 15% of workforce, revises 2023 financial outlook

18d ago, source: The Business Journals

Absci Corp. (Nasdaq: ABSI), the Vancouver, Washington-based AI drug creation company, is laying off 15% of its global workforce, according to a recent filing with the Securities and Exchange ...

Absci Reports Business Updates and Second Quarter 2023 Financial and Operating Results

1mon ago, source: Business Insider

and NEW YORK, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today reported financial and operating results for the quarter ended June ...

Absci Appoints Zach Jonasson, Ph.D., as Chief Financial Officer and Chief Business Officer

1mon ago, source: Yahoo Finance

VANCOUVER, Wash., Aug. 14, 2023 (GLOBE NEWSWIRE) -- Absci Corporation, a generative AI drug creation company, announced today that Zach Jonasson, Ph.D., has been appointed Chief Financial Officer ...

Absci (NASDAQ: ABSI)

8d ago, source: The Motley Fool

Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. It partners with pharma and biotech ...

AbSci (ABSI) Receives a Buy from Berenberg Bank

25d ago, source: Business Insider

See which 3 stocks are most likely to make moves following their insider activities. Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins ...

Biotech company Absci lays off 30 employees, about 15% of staff

25d ago, source: GeekWire

Publicly traded biotech company Absci is laying off 30 employees, or approximately 15% of its workforce. The layoffs, revealed in a SEC filing on Tuesday, are “related to the Company’s ...

Vancouver biotech firm Absci lays off 15 percent of its worldwide staff

23d ago, source: The Columbian

Local biotechnology company Absci announced earlier this week that it has laid off about 15 percent of its staff worldwide. The Vancouver-based company made the news public in an SEC filing Tuesday.

Absci to Participate in Upcoming Investor Conferences

1mon ago, source: Eagle-Tribune

VANCOUVER, Wash. and NEW YORK, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the company will be participating in the ...

Absci Corp.

28d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Absci Corporation (ABSI)

12d ago, source: Yahoo Finance

VANCOUVER, Wash. and NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the company will host its first R&D Day on ...

Absci Reports Business Updates and Second Quarter 2023 Financial and Operating Results

1mon ago, source: Stockhouse

VANCOUVER, Wash. and NEW YORK, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today reported financial and operating results for the quarter ...

Absci to Participate in Upcoming Investor Conferences

1mon ago, source: Yahoo Finance

VANCOUVER, Wash. and NEW YORK, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the company will be participating in the ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...